98%
921
2 minutes
20
Background: Depressive disorder, particularly major depressive disorder (MDD), significantly impact individuals and society. Traditional analysis methods often suffer from subjectivity and may not capture complex, non-linear relationships between risk factors. Machine learning (ML) offers a data-driven approach to predict and diagnose depression more accurately by analyzing large and complex datasets.
Methods: This study utilized data from the National Health and Nutrition Examination Survey (NHANES) 2013-2014 to predict depression using six supervised ML models: Logistic Regression, Random Forest, Naive Bayes, Support Vector Machine (SVM), Extreme Gradient Boost (XGBoost), and Light Gradient Boosting Machine (LightGBM). Depression was assessed using the Patient Health Questionnaire (PHQ-9), with a score of 10 or higher indicating moderate to severe depression. The dataset was split into training and testing sets (80% and 20%, respectively), and model performance was evaluated using accuracy, sensitivity, specificity, precision, AUC, and F1 score. SHAP (SHapley Additive exPlanations) values were used to identify the critical risk factors and interpret the contributions of each feature to the prediction.
Results: XGBoost was identified as the best-performing model, achieving the highest accuracy, sensitivity, specificity, precision, AUC, and F1 score. SHAP analysis highlighted the most significant predictors of depression: the ratio family income to poverty (PIR), sex, hypertension, serum cotinine and hydroxycotine, BMI, education level, glucose levels, age, marital status, and renal function (eGFR).
Conclusion: We developed ML models to predict depression and utilized SHAP for interpretation. This approach identifies key factors associated with depression, encompassing socioeconomic, demographic, and health-related aspects.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11834192 | PMC |
http://dx.doi.org/10.1186/s12911-025-02903-1 | DOI Listing |
Proc Natl Acad Sci U S A
September 2025
Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37240.
Major depressive disorder affects millions worldwide, yet current treatments require prolonged administration. In contrast, ketamine produces rapid antidepressant effects by blocking spontaneous N-Methyl-D-Aspartate (NMDA) receptor signaling, which lifts the suppression of protein synthesis and triggers homeostatic synaptic plasticity. Here, we identify a parallel signaling pathway involving metabotropic glutamate receptor 5 (mGluR5) that promotes rapid antidepressant-like effects.
View Article and Find Full Text PDFCommunity Ment Health J
September 2025
Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, 10027, USA.
Guided by the Ottawa Decision Support Framework, we created a depression care decision aid for Latinx and African American individuals with major depressive disorder (MDD) at a network of Federally Qualified Health Centers. We surveyed 94 African American and Latinx individuals with MDD about their decision making needs. Focus groups elaborated on these preferences.
View Article and Find Full Text PDFNat Sci Sleep
September 2025
Department of Exercise Physiology, School of Sport Science, Beijing Sport University, Beijing, People's Republic of China.
Purpose: Depression patients frequently report sleep disorder. Aerobic exercise is believed to improve sleep quality, but its effect on the overall sleep of depressed patients remains uncertain. This study systematically evaluates the effects of aerobic exercises at different intensities on subjective and objective sleep quality in participants diagnosed with depression or at high risk of depression, from studies covering various depression subtypes (including but not limited to geriatric depression, prenatal depression, and poststroke depression), and examines changes in depression, anxiety, and quality of life following aerobic exercise.
View Article and Find Full Text PDFJAACAP Open
September 2025
Centre for Youth Bipolar Disorder, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Objective: Bipolar disorder (BD) diagnoses require episodes of hypomania and mania as well as depressive episodes. Given the overlap of BD symptoms with symptoms of other psychiatric conditions among youth, misdiagnosis is common. This topic was examined in a large sample of youth clinically referred for BD.
View Article and Find Full Text PDF